144 related articles for article (PubMed ID: 8358398)
21. Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma.
Yeh SH; Liu RS; Wu LC; Yang DJ; Yen SH; Chang CW; Yu TW; Chou KL; Chen KY
Eur J Nucl Med; 1996 Oct; 23(10):1378-83. PubMed ID: 8781144
[TBL] [Abstract][Full Text] [Related]
22. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
23. Reduction of fluoromisonidazole, a new imaging agent for hypoxia.
Prekeges JL; Rasey JS; Grunbaum Z; Krohn KH
Biochem Pharmacol; 1991 Nov; 42(12):2387-95. PubMed ID: 1764122
[TBL] [Abstract][Full Text] [Related]
24. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients.
Rasey JS; Koh WJ; Evans ML; Peterson LM; Lewellen TK; Graham MM; Krohn KA
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):417-28. PubMed ID: 8892467
[TBL] [Abstract][Full Text] [Related]
25. A (99m)Tc-labeled misonidazole analogue: step toward a (99m)Tc-alternative to [18F]fluromisonidazole for detecting tumor hypoxia.
Mallia MB; Mathur A; Sarma HD; Banerjee S
Cancer Biother Radiopharm; 2015 Mar; 30(2):79-86. PubMed ID: 25569675
[TBL] [Abstract][Full Text] [Related]
26. Statistical parametric mapping of hypoxic tissue identified by [(18)F]fluoromisonidazole and positron emission tomography following acute ischemic stroke.
Markus R; Donnan GA; Kazui S; Read S; Hirano T; Scott AM; O'Keefe GJ; Tochon-Danguy HJ; Sachinidis JI; Reutens DC
Neuroimage; 2002 Jun; 16(2):425-33. PubMed ID: 12030827
[TBL] [Abstract][Full Text] [Related]
27. Microfluidic single vessel production of hypoxia tracer 1H-1-(3-[18F]-fluoro-2-hydroxy-propyl)-2-nitro-imidazole ([18F]-FMISO).
Yokell DL; Leece AK; Lebedev A; Miraghaie R; Ball CE; Zhang J; Kolb H; Elizarov A; Mahmood U
Appl Radiat Isot; 2012 Oct; 70(10):2313-6. PubMed ID: 22871433
[TBL] [Abstract][Full Text] [Related]
28. Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Thorwarth D
Phys Med Biol; 2012 Mar; 57(6):1675-84. PubMed ID: 22398239
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of a new [18F]fluoropyridine-based haloacetamide reagent for the labeling of oligonucleotides: 2-bromo-N-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]acetamide.
Kuhnast B; de Bruin B; Hinnen F; Tavitian B; Dollé F
Bioconjug Chem; 2004; 15(3):617-27. PubMed ID: 15149190
[TBL] [Abstract][Full Text] [Related]
30. Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module.
Oh SJ; Chi DY; Mosdzianowski C; Kim JY; Gil HS; Kang SH; Ryu JS; Moon DH
Nucl Med Biol; 2005 Nov; 32(8):899-905. PubMed ID: 16253816
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole.
Lee ST; Scott AM
Semin Nucl Med; 2007 Nov; 37(6):451-61. PubMed ID: 17920352
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole.
Hotchkiss RS; Rust RS; Dence CS; Wasserman TH; Song SK; Hwang DR; Karl IE; Welch MJ
Am J Physiol; 1991 Oct; 261(4 Pt 2):R965-72. PubMed ID: 1928443
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma.
Corroyer-Dulmont A; Pérès EA; Petit E; Durand L; Marteau L; Toutain J; Divoux D; Roussel S; MacKenzie ET; Barré L; Bernaudin M; Valable S
Biol Chem; 2013 Apr; 394(4):529-39. PubMed ID: 23399636
[TBL] [Abstract][Full Text] [Related]
34. Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours.
Bentzen L; Keiding S; Nordsmark M; Falborg L; Hansen SB; Keller J; Nielsen OS; Overgaard J
Radiother Oncol; 2003 Jun; 67(3):339-44. PubMed ID: 12865184
[TBL] [Abstract][Full Text] [Related]
35. Characterization of fluoromisonidazole binding in stroke.
Spratt NJ; Ackerman U; Tochon-Danguy HJ; Donnan GA; Howells DW
Stroke; 2006 Jul; 37(7):1862-7. PubMed ID: 16763190
[TBL] [Abstract][Full Text] [Related]
36. A new precursor for the preparation of 6-[18F]Fluoro-L-m-tyrosine ([18F]FMT): efficient synthesis and comparison of radiolabeling.
VanBrocklin HF; Blagoev M; Hoepping A; O'Neil JP; Klose M; Schubiger PA; Ametamey S
Appl Radiat Isot; 2004 Dec; 61(6):1289-94. PubMed ID: 15388123
[TBL] [Abstract][Full Text] [Related]
37. Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO).
Yuan H; Frank JE; Merrill JR; Hillesheim DA; Khachaturian MH; Anzellotti AI
Curr Radiopharm; 2016; 9(3):235-243. PubMed ID: 27562785
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography.
Martin GV; Caldwell JH; Graham MM; Grierson JR; Kroll K; Cowan MJ; Lewellen TK; Rasey JS; Casciari JJ; Krohn KA
J Nucl Med; 1992 Dec; 33(12):2202-8. PubMed ID: 1460516
[TBL] [Abstract][Full Text] [Related]
39. Topography and temporal evolution of hypoxic viable tissue identified by 18F-fluoromisonidazole positron emission tomography in humans after ischemic stroke.
Markus R; Reutens DC; Kazui S; Read S; Wright P; Chambers BR; Sachinidis JI; Tochon-Danguy HJ; Donnan GA
Stroke; 2003 Nov; 34(11):2646-52. PubMed ID: 14563970
[TBL] [Abstract][Full Text] [Related]
40. Development of a new precursor-minimizing base control method and its application for the automated synthesis and SPE purification of [(18) F]fluoromisonidazole ([(18) F]FMISO).
Lee SJ; Hyun JS; Oh SJ; Yu KH; Ryu JS
J Labelled Comp Radiopharm; 2013 Dec; 56(14):731-5. PubMed ID: 24339013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
